A Polymeric Vesicle System for Combined Lung Cancer Therapy through Chemotherapy and Vasculature Normalization

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Chemotherapy is a primary lung cancer treatment but faces challenges with drug delivery efficiency and side effects.
• Tumor vasculature normalization and targeted co-delivery of agents can enhance therapeutic outcomes.

Purpose of the Study:

• To develop a novel diblock polymeric vesicle nanosystem for enhanced lung cancer chemotherapy.
• To integrate tumor vasculature normalization with co-delivery of paclitaxel (PTX), a nitric oxide (NO) precursor, and zinc oxide nanoparticles (ZnO NPs).

Main Methods:

• A reduction-sensitive diblock polymeric vesicle, (ZnO,NONO)@Ves-PTX, was synthesized.
• PTX was encapsulated in the vesicle bilayer; DETA NONOate (NO precursor) and ZnO NPs were loaded into the core.
• The nanosystem was designed for stimuli-responsive release of NO in the tumor microenvironment (TME) and intracellularly.

Main Results:

• The nanosystem releases NO in the acidic TME, normalizing vasculature and improving drug distribution.
• Intracellular release of NO and Zn2+ ions, along with PTX, synergistically inhibits tumor growth.
• The combined approach demonstrated significant potential in improving chemotherapeutic efficacy for lung cancer.

Conclusions:

• The developed nanosystem offers a promising strategy for enhancing lung cancer chemotherapy.
• Stimuli-responsive co-delivery of therapeutic agents via nanocarriers shows potential for future cancer treatments.